INTRODUCTION
The initial description of Fuchs’ endothelial corneal dystrophy (FECD) in 19101 was made without a slit-lamp biomicroscope and, thus, did not include ‘drop-like’ excrescences beneath the endothelium observed by Vogt in 1921 who is credited with coining the term ‘guttae’ (Latin for drops).2 The origin of gutta has remained obscure. Possible explanations could be that they arise as cellular secretions3 or as extrusions from weak areas in Descemet membrane (DM).4
Limited reports describe morphologies of guttae in FECD. Laing et al described five stages distinguished by size, abnormalities of cells, coalescence of multiple guttae, and contour. They observed several stages in the same cornea.3 Gottsch et al suggest distinct guttae morphologies arise from specific genetic causes of FECD.4
Our studies of a transgenic mouse model of early onset FECD5 suggest novel insights into the origin of guttae.
METHODS
Transgenic mice harbouring the Q455 K mutation in the α 2 collagen VIII gene, confocal microscopy, periodic acid Schiff staining, and transmission electron microscopy (TEM) were described previously.5
RESULTS
Confocal microscopy of a homozygous Q455 K mouse shows endothelial polymegathism and pleomorphism (figure 1A). Laing et al’s stage 1 and stage 2 guttae are present. Also seen is a distinct, sharply raised gutta occurring at a cell border, a morphology ascribed by Gottsch et al to late onset FECD. Histologic sections show differently sized guttae (figure 1B) as seen in figure 1A.
TEM of homozygous Q455 K mouse corneas show large, irregular masses with similar characteristics as the posterior non-banded zone of DM (figure 1C,D). These masses appear intracellular without obvious separation between the adjacent cytoplasm, although they could be extracellular, invaginating the cell membrane in the plane of the section. Focal attachments to DM are present. The irregular border of these masses, internal features consistent with cellular structures, and lack of clear separation with adjacent cytoplasm (figure 1C,D) suggest an intracellular location.
The other major form of this material shows a smoother border with more homogeneous internal features, focal attachment to DM, and areas of separation with the cytoplasm (figure 1E,F), suggesting an extracellular location either by extrusion or death of the cell containing it.
DISCUSSION
A variety of guttae morphologies are seen in human FECD patients and our mouse models. The presence of multiple guttae forms in the same cornea of mice carrying a defined genetic defect suggests variation results from factors beyond the primary gene mutation.
A question arises regarding the origin of these presumably early stage, guttae-like structures in our mouse model. A previously reported feature of FECD endothelium is expanded rough endoplasmic reticulum (RER) (figure 1G).5, 6 In some areas, the dilated RER becomes closely approximated to the basal cell membrane with loss of ribosomes (figure 1H), giving an effaced appearance that suggests the potential for fusion of the cell and RER membranes which could enable attachment between DM and the RER contents. These areas would become the stalk of the gutta (figure 1C–F).
Thus, one mechanism (figure 2A) involves collections of membrane-bound intracellular material which coalesce and possibly fuse with the basal cell membrane (figure 2A). Ultimately, the gutta assumes an extracellular location either by extrusion or death of the cell containing it. An alternative involves localised, cellular secretion of material onto DM (figure 2B).
The similar appearances of guttae in our defined genetic model (figure 1A) with those described in human late onset FECD suggest that significant aspects of the disease are shared across species and genetic aetiologies. If so, elucidation of the origins of guttae in mice and men may provide insights into pathophysiology which could enhance development of novel FECD treatments.
Acknowledgments
Funding Grants from the National Institutes of Health (EY019874), J Willard and Alice S Marriott Foundation, Edward Colburn, Lorraine Collins, Richard Dianich, Mary Finegan, Barbara and Peter Freeman, Stanley Friedler, MD, Herbert Kasoff, Diane Kemker, Jean Mattison, Lee Silverman, Norman Tunkel, PhD (all to ASJ), and Research to Prevent Blindness (to Wilmer Eye Institute).
Footnotes
Correction notice This article has been corrected since it was published Online First. The word ‘gutta’ has been amended to ‘guttae’ in the article title.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data are available upon request from the corresponding author.
References
- 1.Fuchs E. Dystrophia epitheliali corneae. Graefes Arch Clin Exp Ophthalmol. 1910;76:478–508. [Google Scholar]
- 2.Friedenwald H, Friedenwald JS. Epithelial dystrophy of the cornea. Br J Ophthalmol. 1925;9:14–20. doi: 10.1136/bjo.9.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Laing RA, Leibowitz HM, Oak SS, et al. Endothelial mosaic in Fuchs’ dystrophy. A qualitative evaluation with the specular microscope. Arch Ophthalmol. 1981;99:80–3. doi: 10.1001/archopht.1981.03930010082007. [DOI] [PubMed] [Google Scholar]
- 4.Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defines a distinct subtype of Fuchs corneal dystrophy. Investig Ophthalmol Vis Sci. 2005;46:1934–9. doi: 10.1167/iovs.04-0937. [DOI] [PubMed] [Google Scholar]
- 5.Jun AS, Meng H, Ramanan N, et al. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet. 2012;21:384–93. doi: 10.1093/hmg/ddr473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Engler C, Kelliher C, Spitze AR, et al. Unfolded Protein Response in Fuchs Endothelial Corneal Dystrophy: a Unifying Pathogenic Pathway? Am J Ophthalmol. 2010;149:194–202. doi: 10.1016/j.ajo.2009.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]